Maker of semaglutide (Wegovy, Ozempic). Its GLP-1 franchise is the cost line employers are rationing, and the market Ilant is built around.
Maker of semaglutide (Wegovy, Ozempic). Its GLP-1 franchise is the cost line employers are rationing, and the market Ilant is built around.
GlobeNewswire
Global Weight Loss Market Size, Share, Trends & Forecast (2026-2036) Featuring Novo Nordisk, Boehringer Ingelheim, Herbalife, WW Int'l, Medtronic and More | GLP-1 Drugs, Oral Therapies, Coverage, and Telehealth Propel Market to $244 Billion by 2036
Proactive
Novo Nordisk faces tougher GLP-1 competition, Citi says
Stocktwits
LLY Vs NVO: Lilly’s Retatrutide Beats Novo’s Ozempic In Head-To-Head Trial — Retatrutide More Than Doubles Weight Loss
TIKR
US Judge Denies Novo Nordisk Request To Block Eli Lilly Weight Loss Drug Ads
GlobeNewswire
Novo Nordisk A/S - share repurchase programme
Investing.com
US judge refuses to block Eli Lilly weight-loss drug ads, rules against Novo Nordisk
GlobeNewswire
Novo Nordisk A/S - share repurchase programme
36kr.com
Is AI disrupting the pharmaceutical industry?
GlobeNewswire
Novo Nordisk A/S - share repurchase programme
InvestorsHub
Citi Cuts Novo Nordisk Price Target to DKK 296 on Limited Margin Growth Outlook
Investing.com
Novo Nordisk stock target cut at Citi on lack of margin growth
StartupMafia - News from startup industry -
Nordic Life Science: Week in Review, 2–9 October 2026
GlobeNewswire
Novo Nordisk A/S – Share repurchase programme
InvestorsHub
FDA Extends Review of Novo Nordisk Haemophilia A Treatment Denecimig
StreetInsider.com
FDA extends review of Novo Nordisk's haemophilia A drug denecimig
Stocktwits
Novo Nordisk Holds Its 2026 Outlook As FDA Review Of Its Blood Disorder Drug Runs Long
Proactive
Eli Lilly obesity drug data adds pressure on Novo Nordisk
FierceBiotech
Biopharma recruiters see ‘signs of recovery’ as layoffs remain cool in Q3’26
Quartz
Novo Nordisk Wegovy pill weight loss switch study results
GuruFocus.com
Novo Nordisk Delivers Fresh Challenge to Eli Lilly With Ozempic Data